Advanced Biomedical Technologies, Inc. announced earnings results for the third quarter ended July 31, 2021. For the third quarter, the company announced sales was USD 180 compared to USD 961 a year ago. Operating loss was USD 111,772 compared to USD 116,441 a year ago. Net loss was USD 198,713 compared to USD 205,225 a year ago. For the nine months, sales was USD 47,508 compared to USD 61,251 a year ago. Operating loss was USD 313,564 compared to USD 336,420 a year ago. Net loss was USD 559,846 compared to USD 478,666 a year ago. Basic loss per share from continuing operations was USD 0.01 compared to USD 0.01 a year ago.